Xenon Pharmaceuticals Inc.
XENE· Nasdaq
XENEXenon Pharmaceuticals Inc.
Filed Nov 10, 2015 · 10-Q · 41 days after period end · 0001564590-15-010362
| Metric | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|
| Revenue | $4.29M | $13.19M | $10.79M |
| Net Income | -$3.83M | $9.19M | $6.38M |
| EPS Diluted | -$0.27 | $1.69 | $0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenon Pharmaceuticals Inc. · CIK 1582313 · Engraved from SEC EDGAR
ended Sep 30, 2015 · filed Nov 10, 2015 · 41 d after period end
